Evidence map›Paper›PMID 33645240›Full record

Observational studyJournal of managed care & specialty pharmacy2021

Effect of clinical pharmacist interventions on cost in an integrated health system specialty pharmacy.

Cory Lankford, Jillian Dura, Annie Tran, Simon W Lam, Bryan Naelitz, Marc Willner, Kristel Geyer

Abstract readObservational Study
In one paragraph

Observational study in Journal of managed care & specialty pharmacy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. The impact of early oral anticancer medication monitoring through electronic patient assessments.American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists · 2026
    Trial
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Impact of VA Hematology/Oncology Clinical Pharmacy Practitioners in the Review of Community Prescriptions for Specialty Medications.Federal practitioner : for the health care professionals of the VA, DoD, and PHS · 2024
    Article
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cory LankfordDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.
Jillian DuraDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.
Annie TranDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.
Simon W LamDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.
Bryan NaelitzLerner College of Medicine, Cleveland Clinic, Cleveland, OH.
Marc WillnerDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.
Kristel GeyerDepartment of Pharmacy, Cleveland Clinic, Cleveland, OH.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Practice Patterns, Pharmacists'AdolescentAdultAgedAged, 80 and overAmbulatory Care FacilitiesAntineoplastic AgentsCost SavingsDelivery of Health Care, IntegratedFemaleHumansMaleMiddle AgedNeoplasmsOhioPharmacy Service, HospitalAntineoplastic Agents

Identifiers

PMID33645240
PMCPMC10391180

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.